VRDN
#1820
Viridian Therapeutics, Inc. - Common Stock
22.9 6 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.79%
Changement Mensuel
+9.33%
Evolution sur 6 mois
-24.32%
Changement Annuel
+2.27%
Clôture Précédente
22.7 8
Open
22.9 6
Low
22.9 6
High
22.9 6
Volume
93
Financials
- Market Capitalization 2.6 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.71
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1814 |  NRIX Nurix Therapeutics, Inc. - Common stock | 25.32 USD | -1.94% | -4.52% | +2.06% | +125.87% | 2.63 B USD | ||
| 1818 |  NKTR Nektar Therapeutics - Common Stock | 76.37 USD | +4.99% | +3.19% | +3.82% | +4.23% | 2.61 B USD | ||
| 1829 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 10.09 USD | -0.79% | +2.75% | +6.89% | +22.01% | 2.58 B USD | ||
| 1833 |  PGEN Precigen, Inc. - Common Stock | 7.14 USD | +1.85% | +0.42% | +1.13% | +54.21% | 2.56 B USD |